120 results
Page 3 of 6
8-K
EX-99.1
0slcxsm42kc3ek65hyh
15 Jun 21
Other Events
6:50am
8-K
EX-99.1
o0go29yj 1e7l
4 May 21
Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
7:14am
8-K
EX-99.1
ibv6sa xd
12 Apr 21
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
7:17am
8-K
EX-99.1
tjcml53
18 Mar 21
Sage Therapeutics Announces Continued Positive Zuranolone Data for Both
6:55am
8-K
EX-99.1
f46yalhf4e mp
24 Feb 21
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
EX-99.1
54p4zxl02lm08 yxbc
7 Jan 21
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
4:14pm
8-K
EX-99.1
qszdf361tofrz69c ajd
5 Nov 20
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
EX-99.1
yfp7u 8lzv
15 Oct 20
Sage Therapeutics Announces Positive Interim, Topline Zuranolone
9:14am
8-K
EX-99.1
fkhrz yirojh
10 Aug 20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
EX-99.1
69mjf0iy
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm
8-K
EX-99.1
2qftkx0f5l kuky4zd
7 Apr 20
Sage Therapeutics Announces Restructuring to Advance Corporate Strategy and Pipeline
4:25pm
8-K
EX-99.1
zm2s4omm
18 Mar 20
Sage Therapeutics Announces Development Plan for Zuranolone(SAGE-217) Following
6:57am